February 21, 2024 – Talk Bio

Actionable Insights Powered by AI

ViiV’s Long-Acting Cabenuva Outperforms Daily Oral Therapy in Phase III Study

1 year ago talkbio0Tagged Adherence (attribute), cabenuva, Daily, HIV, Participant, Standard of Care

cabenuva, Daily, Standard of Care, Adherence (attribute), HIV, Participant, daily

AbbVie CEO Gonzalez to Step Down, Robert Michael named Successor in Seamless Transition

1 year ago talkbio0Tagged AbbVie's, company's, Gonzalez, Transition Mutation

Gonzalez, AbbVie’s, company’s, Transition Mutation